728 related articles for article (PubMed ID: 9421301)
1. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
2. AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.
Muller C; Endlich K; Helwig JJ
Br J Pharmacol; 1998 Jul; 124(5):946-52. PubMed ID: 9692780
[TBL] [Abstract][Full Text] [Related]
3. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide.
Fernandes L; Loiola RA; Tostes RC; Nigro D; Fortes ZB; de Carvalho MH
Peptides; 2005 Dec; 26(12):2458-63. PubMed ID: 16043265
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.
Hakam AC; Hussain T
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1430-6. PubMed ID: 16380464
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats.
Rivera-Jardón FF; Castro-Moreno P; Figueroa-Guillén ES; Gallardo-Ortíz IA; Godínez-Hernández D; Ibarra-Barajas M
Proc West Pharmacol Soc; 2009; 52():47-9. PubMed ID: 22128421
[TBL] [Abstract][Full Text] [Related]
8. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
10. Role of shear stress in nitric oxide-dependent modulation of renal angiotensin II vasoconstriction.
Endlich K; Muller C; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1999 Aug; 127(8):1929-35. PubMed ID: 10482926
[TBL] [Abstract][Full Text] [Related]
11. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway.
de Godoy MA; de Oliveira AM; Rattan S
J Pharmacol Exp Ther; 2004 Oct; 311(1):394-401. PubMed ID: 15178697
[TBL] [Abstract][Full Text] [Related]
13. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
14. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis.
Chaki S; Inagami T
Mol Pharmacol; 1993 Apr; 43(4):603-8. PubMed ID: 7682650
[TBL] [Abstract][Full Text] [Related]
15. Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.
Zwart AS; Davis EA; Widdop RE
Br J Pharmacol; 1998 Dec; 125(7):1429-36. PubMed ID: 9884070
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and renal medullary blood flow in Lyon rats.
Sarkis A; Liu KL; Lo M; Benzoni D
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F365-72. PubMed ID: 12529274
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
18. The potential role of nitric oxide in angiotensin II-receptor blockade.
Cachofeiro V; Maeso R; Muñoz-Garcia R; Lahera V
Blood Press Suppl; 1996; 2():29-35. PubMed ID: 8913537
[TBL] [Abstract][Full Text] [Related]
19. Prejunctional AT(1) receptor subtype-dependent modification of neurotransmitter releases in canine isolated splenic arteries.
Komiyama J; Yang XP; Chiba S
Auton Autacoid Pharmacol; 2003; 23(5-6):297-305. PubMed ID: 15255814
[TBL] [Abstract][Full Text] [Related]
20. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
